Sustained Cyclosporine-Induced Erythropoietic Response in Identical Male Twins with Diamond-Blackfan Anemia

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 11, 2003, Pages 914-918

  Bobey, Nicola A M ^a   Carcao, Manuel ^b   Dror, Yigal ^b   Freedman, Melvin H ^b   Dahl, Niklas ^c   Woodman, Richard C ^a,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY CHILDREN S HOSPITAL   (Sweden)

^d Clinical Affairs   (United States)

Author keywords

Cyclosporine; Diamond Blackfan anemia; Pure red cell aplasia

Indexed keywords

CYCLOSPORIN;

ARTICLE; BLACKFAN DIAMOND ANEMIA; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; BURST FORMING UNIT E; CASE REPORT; CELL DIFFERENTIATION; CHILD; CLONOGENIC ASSAY; COLONY FORMING UNIT; COLONY FORMING UNIT E; CORTICOSTEROID THERAPY; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; DRUG INDUCED DISEASE; ERYTHROCYTE; ERYTHROPOIESIS; HUMAN; MALE; MONOZYGOTIC TWINS; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE ACTIVATION;

ANEMIA, DIAMOND-BLACKFAN; CYCLOSPORINE; DISEASES IN TWINS; ERYTHROPOIESIS; HUMANS; INFANT; MALE; TIME FACTORS; TWINS, MONOZYGOTIC;

EID: 0242524442     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200311000-00018     Document Type: Article

References (23)

1. Halperin, DS, Freedman MH. Diamond-Blackfan anemia: etiology, pathophysiology, and treatment. Am J Pediatr Hematol Oncol. 1989;11: 380-394.
2. Dianzani I, Garelli E, Ramenghi U. Diamond-Blackfan anemia: a congenital defect in erythropoiesis. Haematologica. 1996;81:560-572.
3. Willig T, Niemeyer CM, Leblanc T, et al. Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. Pediatr Res. 1999;46:553-561.
4. Ball SE, McGuckin CP, Jenkins G, et al. Diamond-Blackfan anaemia in the U.K.: analysis of 80 cases from a 20-year birth cohort. Br J Haematol. 1996;94:645-653.
5. Willig T, Ball SE, Tchemia G. Current concepts and issues in Diamond-Blackfan anemia. Curr Opinion Hematol. 1998;5:109-115.
6. Mugishima H, Gale RP, Rowlings PA, et al. Bone marrow transplantation for Diamond-Blackfan anemia. Bone Marrow Transplant. 1995;15:5-58.
7. El-Beshlawy A, Youssry Ibrahim I, Rizk S, et al. Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporine therapy results. Pediatrics. 2002;110:e44.
8. Alessandri AJ, Rogers PC, Wadsworth LD, Davis JH. Diamond-Blackfan anemia and cyclosporine therapy revisited. J Pediatr Hematol Oncol. 2000;22:176-179.
9. Willig TN, Draptchinskaia N, Dianzani I, et al. Mutation in ribosomal protein S19 gene and Diamond-Blackfan anemia: wide variations in phenotypic expression. Blood. 1999;94:4294-4306.
10. Nathan DG, Clarke BJ, Hillman DG, et al. Erythroid precursors in congenital hypoplastic anemia. J Clin Invest. 1978;61:489-498.
11. Perdahl EB, Naprstek BL, Wallace WC, et al. Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis. Blood. 1994;3:645-650.
12. Santucci MA, Bagnara GP, Strippoli P, et al. Long-term bone marrow cultures in Diamond Blackfan anemia reveal a defect of both granulomacrophage and erythroid progenitors. Exp Hematol. 1999;27:9-18.
13. Hoffman R, Zanjani ED, Vila J, et al. Diamond-Blackfan syndrome: Lymphocyte-mediated suppression of erythropoiesis. Science. 1976;193:899-900.
14. Freedman MH, Saunders EF. Diamond Blackfan syndrome: evidence against cell-mediated erythropoietic suppression. Blood. 1978;51:1125-1128.
15. Gazda H, Lipton JM, Willig TN, et al. Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease. Blood. 2001;97:2145-2150.
16. Waterkotte GW, McElfresh AE. Congenital pure red cell hypoplasias in identical twins. Pediatrics. 1974;54:646-647.
17. Dianzani I, Garelli E, Valtolina S, et al. Diamond-Blackfan anemia in the Italian population. Am J Hum Genetics. 1998;63(suppl):102a.
18. Findlay JL, Shahidi NT. Cyclosporine A (CyA) induced remission in Diamond-Blackfan anemia (DBA). Blood. 1984;64(suppl 1):104a.
19. Shevach EM. The effects of cyclosporine A on the immune system. Annu Rev Immunol. 1985;3:397-423.
20. Moulian N, Bidault J, Planche C, et al. Two signaling pathways can increase Fas expression in human thymocytes. Blood. 1998;92:1297-1307.
21. Hasegawa D, Kojima S, Tatsumi E, et al. Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. Blood. 1998;91:2793-2799.
22. Selleri C, Maciejewski JP, Sato T, et al. Interferon-γ constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood. 1996;87:4149-4157.
23. Kalman V, Klimpel GR. Cyclosporin A inhibits the production of gamma interferon (IFN-gamma) but does not inhibit production of virus-induced IFN alpha/beta. Cell Immunol. 1983;78:122-129.